Approximately half of patients with ST-segment elevation myocardial infarction (STEMI)
present with noninfarct related multivessel coronary artery disease (CAD) during primary …

Background: The relative benefit of immediate complete revascularization, staged complete
revascularization, and culprit-only percutaneous coronary intervention (PCI) remains …

Multivessel percutaneous coronary intervention (PCI) early after acute myocardial infarction
(AMI) is discouraged because of the potential for increased complications. However, with …

BACKGROUND: The optimal percutaneous interventional strategy for dealing with
significant non-culprit lesions in patients with multivessel disease (MVD) with acute …

Introduction There have been no prospective randomized trials that enable the best strategy
and timing to be determined for revascularization in patients with non-ST-segment elevation …

Background The best approach for revascularization of multi-vessel coronary disease in
patients with ST-elevation myocardial infarction (STEMI) undergoing primary percutaneous …

Background The optimal revascularization approach for patients with multivessel coronary
artery disease (MVCAD) is controversial. We sought to investigate outcomes in patients …

Background The best strategy for the treatment of the non-infarct artery in patients with ST-
elevation myocardial infarction (STEMI) and multivessel disease (MVD) undergoing primary …

Background For patients with ST‐segment–elevation myocardial infarction (STEMI) and
multivessel coronary artery disease, the optimal treatment of the non‐infarct‐related artery …

Background: Optimal treatment strategy of patients with ST elevation myocardial infarction
(STEMI) and multivessel coronary artery disease (CAD) undergoing primary angioplasty is …